| 000 | 01257 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513123815.0 | ||
| 264 | 0 | _c19970911 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAubrecht, J | |
| 245 | 0 | 0 |
_aTissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cAug 1997 |
||
| 300 |
_a1102-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenine Phosphoribosyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHypoxanthine Phosphoribosyltransferase _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aThioguanine _xadministration & dosage |
| 700 | 1 | _aGoad, M E | |
| 700 | 1 | _aSchiestl, R H | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 282 _gno. 2 _gp. 1102-8 |
|
| 999 |
_c9241999 _d9241999 |
||